MD SB392

Maryland Technology Development Corporation must establish a grant and loan program to fund Long COVID research, product development, and manufacturing within the state

Creates the Maryland Long COVID Research Fund as a special, nonlapsing fund administered by the Corporation, with funding from state appropriations, interest earnings, and other sources

Corporation must contract with an independent scientific peer review committee of Long COVID experts to evaluate and rank research proposals and recommend grant/loan awards

"Long COVID" definition follows the National Academy of Sciences' 2024 publication "A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences," with automatic updates if the definition is amended

Annual report required to the Governor and General Assembly by January 1 detailing grant recipients, funding amounts, research descriptions, economic impact indicators, and program improvement recommendations; effective date July 1, 2026